Infectious disease researchers publish routes to ensure lessons are learned from COVD-19 when using PCR for monkeypox diagnosis

News - The paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.

16 August 2022
LGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing

News - The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

02 August 2022
LGC launches free app-based cannabis testing training to support cannabis testing laboratories in their learning

News - Easy-to-use app-based microlearning provides training in a range of cannabis-related topics

01 July 2022
LGC to distribute InBio’s food allergen reference materials and immunoassays

News - Expands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification

23 June 2022
LGC Board change

News - Update

13 June 2022
National agrifood partnership launched at Queen’s University Belfast

News - We're pleased to launch the Centre for Excellence in Agriculture and Food Integrity, a strategic partnership to enhance and future-proof the UK agrifood industry through the development and application of innovative scientific-measurement solutions and digital technologies for greater assurance of the sustainability, reliability, safety and productivity of inherent supply chains.

26 May 2022
Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

17 May 2022
LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing

27 April 2022
Successful completion of leading TNAC's new home at Oxford Technology Park

News - Purpose-built R and D and manufacturing facility will be a vital hub for LGC

08 April 2022
LGC acquires Rapid Genomics, bolstering its position in the application of NGS for high-throughput genotyping market in AgBio

News - Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing

01 April 2022